| Autor: |
Eric Larose, Julie Côté, Josep Rodés-Cabau, Bernard Noël, Gerald Barbeau, Edith Bordeleau, Santiago Miró, Bernard Brochu, Robert Delarochellière, Olivier Bertrand |
| Zdroj: |
International Journal of Cardiovascular Imaging; Jun2009, Vol. 25 Issue 5, p519-527, 9p |
| Abstrakt: |
Abstract Cardiovascular magnetic resonance (CMR) very early after primary percutaneous coronary intervention (PPCI) may lead to instability or early stent complications. However, CMR in the hyperacute phase of STEMI may improve risk stratification. We investigated feasibility and safety of CMR in the hyperacute phase of STEMI immediately after PPCI. One hundred and twenty eight consecutive patients immediately after PPCI for STEMI. Sixty four underwent CMR P = NS). CMR (32 ml gadolinium contrast) immediately after PPCI (180 ml iodine contrast) did not increase nephropathy. CMR did not increase major adverse cardiac events (5 vs. 8%, P = 0.16) or recurrence of angina (6 vs. 8%, P = 0.73) at 6 months. CMR immediately after PPCI is feasible and safe, allowing very early risk stratification in STEMI. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink